Stockscreener 앱 받기
3.41
1.49%
0.05
시간 외 거래:
3.40
-0.01
-0.29%
전일 마감가:
$3.36
열려 있는:
$3.32
하루 거래량:
2.83M
Relative Volume:
1.93
시가총액:
$202.31M
수익:
$1.04B
순이익/손실:
$111.90M
주가수익비율:
1.7309
EPS:
1.9701
순현금흐름:
$205.80M
1주 성능:
-12.56%
1개월 성능:
-61.47%
6개월 성능:
-76.48%
1년 성능:
-72.52%
1일 변동 폭
$3.26
$3.46
1주일 범위
$3.23
$4.06
52주 변동 폭
$3.23
$15.55
Embecta Corp Stock (EMBC) Company Profile
명칭
Embecta Corp
전화
(862) 401-0000
주소
300 KIMBALL DRIVE, PARSIPPANY
Compare EMBC vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EMBC
Embecta Corp
|
3.41 | 199.34M | 1.04B | 111.90M | 205.80M | 1.9701 |
ISRG
Intuitive Surgical Inc
|
431.87 | 148.77B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.51 | 39.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
38.55 | 33.19B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
63.78 | 30.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
203.79 | 28.83B | 5.54B | 1.52B | 1.74B | 10.37 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 개시 | Mizuho | Neutral |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-27 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-10-20 | 개시 | Wolfe Research | Peer Perform |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-09-08 | 개시 | BTIG Research | Neutral |
| 2022-08-01 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-06-21 | 개시 | BofA Securities | Underperform |
모두보기
Embecta Corp 주식(EMBC)의 최신 뉴스
Embecta downgraded by S&P on demand weakness, market share loss - Investing.com
Why Embecta stock plummeted today - MSN
Embecta stock rating held at Neutral by BTIG after investor meetings By Investing.com - Investing.com Nigeria
Number of shareholders of Embecta Corp. – NASDAQ:EMBC - TradingView
Embecta Corp. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts - Yahoo Finance
Embecta (EMBC) Is Down 60.7% After Dividend Cut And Buyback ShiftWhat's Changed - simplywall.st
Investors can hear embecta management at BofA conference on May 13 - Stock Titan
Embecta Corp. (EMBC) Stock Analysis: A High Dividend Yield and Potential Upside of 122.22% - DirectorsTalk Interviews
Deeply Undervalued Global Medical Device Company – Embecta Corp. (EMBC) - The Acquirer's Multiple
Embecta Corp. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:EMBC) 2026-05-07 - Seeking Alpha
Is It Too Late To Consider Buying Embecta Corp. (NASDAQ:EMBC)? - Moomoo
Embecta: A Sharp Decline On Q2 Earnings, But There's Still No Opportunity (NASDAQ:EMBC) - Seeking Alpha
Embecta Stock Plunges 57.8% on Weak Q2 2026 Results and Lowered ForecastNews and Statistics - IndexBox
Embecta (EMBC): Do Buybacks Amid Losses Reveal Capital Discipline or Strategic Uncertainty? - Yahoo Finance
Investors urged to join probe after Embecta cuts revenue outlook and dividend, shares drop sharply - Pluang
BTIG Maintains Embecta(EMBC.US) With Hold Rating - Moomoo
Investigation Launched into Embecta Corp. by Johnson Fistel - Intellectia AI
Embecta Corp. Shareholders Are Encouraged to Reach Out to - GlobeNewswire
Headwinds Slam into Embecta, Stock Nosedives - Medical Device and Diagnostic industry
Embecta Corp. (NASDAQ:EMBC) Q2 2026 Earnings Call Transcript - Insider Monkey
Mizuho cuts Embecta stock price target on weak US sales performance - Investing.com UK
BTIG downgrades Embecta stock rating on U.S. market share loss By Investing.com - Investing.com India
Embecta (EMBC) Margin Expansion To 12.9% Tests Bearish Earnings Sustainability Narrative - simplywall.st
Embecta Q2 FY2026 slides: sharp miss triggers guidance cut, stock plunge - Investing.com Australia
BTIG downgrades Embecta (EMBC) - MSN
Embecta’s Earnings Call: Growth Bets Amid Sharp Setback - TipRanks
Why Embecta Stock Plummeted Today - The Motley Fool
Why Embecta Stock Plummeted Today - The Motley Fool
Embecta declares $0.01 quarterly dividend payable June 15 By Investing.com - Investing.com Australia
Embecta Q2 2026 Earnings Call Transcript - MarketBeat
Embecta Cuts FY26 View To Rev $1.02B-$1.04B >EMBC - Moomoo
BTIG downgrades Embecta stock rating on U.S. market share loss - Investing.com
Embecta Corp. Q2 2026 Earnings Call Summary - Yahoo Finance
Embecta (EMBC) Q2 2026 Earnings Transcript - AOL.com
Yacktman Asset Mgmt, AMG Yacktman Fund Report Stakes in Embecta (EMBC) - Stock Titan
Embecta ‘disappointed’ with Q2 results that fell below expectations, cuts 2026 guidance - Drug Delivery Business
Embecta forecasts $1.015B-$1.035B FY 2026 revenue while launching $100M buyback and cutting dividend to $0.01 - MSN
Embecta Corp. 3Q 2026: Revenue $221.8M, EPS $(0.07) — 10-Q Summary - TradingView
Embecta (NASDAQ: EMBC) revenue drops as debt, buyback and Owen Mumford deal reshape 2026 - Stock Titan
Embecta Corp (EMBC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.05%
3.17%
자본화:
|
볼륨(24시간):